SCHEMBL18975996

SCHEMBL18975996

Cn1cc(NC(=O)OC(C)(C)C)cc1C(=O)Nc1ccc2sc(C(=O)N3CCSCC3)cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 2/20 0.39
▸ HRH4 Q9H3N8 1/20 0.39
▸ ACKR3 P25106 1/20 0.36
▸ HDAC1 Q13547 2/20 0.36
▸ TSHR P16473 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ LEF1 Q9UJU2 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ PRKDC P78527 1/20 0.34
▸ DRD2 P14416 1/20 0.33
▸ AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21941027 0.92 ALDH1A1 (0.43) SYKHRH4ACKR3HDAC1LEF1
SCHEMBL18976117 0.91 GAA (0.45) SYKHRH4HPGDGAAPRKDC
SCHEMBL20581237 0.88 HRH4 (0.43) SYKHRH4HDAC1TSHRSMN1; SMN2
SCHEMBL22824938 0.86 HDAC1 (0.43) ACKR3HDAC1LEF1ACHEBACE1
SCHEMBL18314047 0.86 LEF1 (0.44) ACKR3HDAC1LEF1ALDH1A1KDM4E
SCHEMBL18976489 0.84 AR (0.41) ALDH1A1KDM4EHPGDCASP1CASP7
SCHEMBL21941140 0.83 LMNA (0.42) SYKACKR3HDAC1LEF1ACHE
SCHEMBL18976466 0.82 HRAS (0.41) SYKHRH4SMN1; SMN2ALDH1A1KDM4E
SCHEMBL27118694 0.82 LEF1 (0.38) HDAC1LEF1ACHEBACE1PRKDC
SCHEMBL21941146 0.82 CYP1A2 (0.43) ACKR3HDAC1LEF1HPGDACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed
WO-2017098257-A1 PBD ANTIBACTERIAL AGENTS KING'S COLLEGE LONDON (GB) 2017-06-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS SYK 3347/4885HRH4 13/4885ACKR3 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback